CASE REPORT

Allogeneic cortical struts and bone granules for challenging alveolar reconstructions

https://onlinelibrary.wiley.com/doi/10.1111/jerd.12639

Robert Würdinger & Phil Donkiewicz, J Esthet Restor Dent. 2020 Sep 13. doi: 10.1111/jerd.12639. Online ahead of print.

In this case series, the regeneration of five complex alveolar bone defects is demonstrated using maxgraft® cortico, maxgraft® granules and Jason® membrane.

Abstract

Objective: The shell technique is a well-established procedure for GBR with which extensive osseous defects can be predictably restored by using cortical bone struts harvested from various intraoral aspects. Recent publications have demonstrated comparable results for autologous and allogeneic bone grafts, whereas the evidence on allogeneic cortical struts remains limited.

Clinical considerations: In this case series, we demonstrate the regeneration of five complex alveolar bone defects in four patients with subsequent insertion of fixed dental implants. In all cases, cortical struts made from human donor bone were applied in combination with allogeneic bone granules and collagen membranes.

Conclusions: Similar to autologous cortical shells, the allogeneic struts functioned by creating an immobile container with which the osseous defects in all patients could be successfully restored, enabling placement of dental implants in accordance with the treatment plan. Even when the containers were solely filled with allogeneic granules, vascularized healthy tissue was present at re-entry, demonstrating the vast potential of these materials for applications in dentistry.

Clinical significance: Especially when it comes to regeneration of complex alveolar bone defects, autologous bone grafts are often outlined as the only treatment modality. Here we show that innovative biomaterials like allogeneic bone grafts hold the potential to mimic the functions of autologous bone transplants and provide excellent clinical results without the requirement of a second surgical side for bone harvesting and no risk of donor-site morbidity.

Robert Würdinger

, , , ,
 0

Leave A Comment

Related Posts